FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry, and deals with application of somastostatin or one of its agonistic analogues for manufacturing medication for regulation of follicular reserve of ovary or to application of antagonistic analogue of somastostatin for manufacturing medication for acceleration of beginning of resting follicle growth in women who do not have menopause yet.
EFFECT: reduction of depletion of ovarian follicular reserve in curse of time in women, who do not have menopause yet, as well as elaboration of means for determining impact of compounds on acceleration or retardation of follicle growth in carrying out toxicological tests.
16 cl, 3 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PROTEIN GBD-SSTAD-SSTAD, A METHOD FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2722849C1 |
| METHOD FOR MODULATING CELL PROLIFERATION OF THYROID MEDULLARY CARCINOMA | 2005 |
|
RU2317824C2 |
| METHOD FOR MODULATING CELL PROLIFERATION OF MEDULLARY THYROID CARCINOMA | 2002 |
|
RU2275934C2 |
| METHOD OF MODULATION OF PROLIFERATION OF CELLS OF THYROID GLAND MEDULLARY CARCINOMA | 2002 |
|
RU2352578C2 |
| SOMATOSTATIN AGONISTS | 2000 |
|
RU2263677C2 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
| CHIMERIC EQUIVALENTS OF LIGANS OF SOMATOSTATIN AND DOPERMINE RECEPTORS, PHARMACEUTICAL COMPOSITIONS BASED ON THEM AND MODALTIES OF SOMATOSTATIN AND/DOPERMINE RECEPTORS | 2004 |
|
RU2329273C2 |
| COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | 2012 |
|
RU2739037C2 |
| SOMATOSTATIN AGONISTS | 2002 |
|
RU2259375C2 |
